07:00 , Jun 16, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: G protein pathway suppressor 2 (GPRS2)

Endocrine/metabolic disease INDICATION: Obesity; diabetes Patient sample and mouse studies suggest GPRS2 could help treat obesity and Type II diabetes. GPRS2 levels were lower in visceral adipose tissue (VAT) macrophages of patients with obesity or...
07:00 , Aug 2, 2012 |  BC Innovations  |  Distillery Techniques

Technology: Markers

Approach Summary Licensing status Publication and contact information Markers Subtype-specific somatic mutations in medulloblastoma Identification of new subtype-specific somatic mutations in medulloblastoma could aid the development of new treatments for the disease. Whole-exome hybrid capture...